not applicable

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-018118-21

Femme Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The aim of this study is to investigate the efficacy and safety of OXN PR in the treatment of BPS and to further support the evidence for the use of opioids in this indication. The main objective is to estimate the Subjects’ average pain over the last 24 Hours assessed at each study Visit during treatment with OXN PR compared with placebo as measured by the Pain Intensity Scale (NRS 0 – 10).


Critère d'inclusion

  • Bladder Pain Syndrome (BPS), formerly addressed as IC/PBS (interstitial cystitis /Painful Bladder Syndrome)